, France
Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs? starving while specifically targeting the most immunosuppressive ones
Technologie - Deeptech
Technologies
Business model
B2B
Présence
N° Immat:
Secteurs cibles
Santé / Pharma / Médecine
Métiers cibles
Partenariat(s) recherché(s)
Partenaires